BJO

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chia, E-M
Right arrow Articles by Wang, J J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chia, E-M
Right arrow Articles by Wang, J J
British Journal of Ophthalmology 2003;87:392-395
© 2003 BMJ Publishing Group


SINGAPORE SERI-ARVO MEETING

Unilateral visual impairment and health related quality of life: the Blue Mountains Eye Study

E-M Chia, P Mitchell, E Rochtchina, S Foran, J J Wang

Department of Ophthalmology, University of Sydney, Sydney, Australia

Correspondence to:
Correspondence to:
Paul Mitchell, MD, PhD, University of Sydney Department of Ophthalmology (Centre for Vision Research, Westmead Hospital), Hawkesbury Road, Westmead, NSW, Australia, 2145;
paul_mitchell{at}wmi.usyd.edu.au


ABSTRACT
Background: There has been considerable recent interest in the impact of unilateral visual impairment on functional status and wellbeing, particularly in relation to second eye cataract surgery.

Aim: To determine if unilateral visual impairment has a measurable impact on health related quality of life (HRQOL) in an older community, as assessed by the generic, multidimensional 36 item short form health survey (SF-36).

Methods: All participants of the second cross sectional Blue Mountains Eye Study (n = 3508) were invited to attend comprehensive eye examinations and complete an SF-36 questionnaire. Unilateral visual impairment was defined as visual acuity (VA) <6/12 in the worse eye and >=6/12 in the better eye. Mild visual impairment was defined as VA <6/12 but >=6/24, moderate as VA <6/24 but >=6/60, and severe (blindness) as VA <6/60 in the worse eye. Cases with amblyopia (n = 48) were excluded.

Results: Complete data were available for 3108 participants; 227 (7.3%) had unilateral visual impairment (148 mild, 29 moderate, 50 severe). Moderate to severe non-correctable unilateral impairment was associated with poorer SF-36 profiles. After adjusting for age and sex, this group had significantly poorer scores than the unimpaired group in three of eight domains (p<0.05); limitations as a result of physical problems, social function, limitations because of emotional problems, and in the mental component score. Mental domains were more affected than physical domains. Unilateral impairment from undercorrected refraction did not measurably affect HRQOL.

Conclusions: Moderate to severe non-correctable unilateral visual impairment caused by eye diseases such as cataract had a measurable impact on HRQOL.


Keywords: unilateral visual impairment; quality of life; SF-36; epidemiology; visual function; cataract surgery; Blue Mountains Eye Study




This article has been cited by other articles:


Home page
British Journal of Visual ImpairmentHome page
S.-Y. Wu, B. Nemesure, A. Hennis, and M. C. Leske
Visual acuity impairment and vision-related quality of life: the Barbados Eye Studies
British Journal of Visual Impairment, January 1, 2009; 27(1): 9 - 24.
[Abstract] [PDF]


Home page
Br. J. Ophthalmol.Home page
S Polack, H Kuper, Z Wadud, A Fletcher, and A Foster
Quality of life and visual impairment from cataract in Satkhira district, Bangladesh
Br. J. Ophthalmol., August 1, 2008; 92(8): 1026 - 1030.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
E. M. Aldrich, A. W. Lee, C. S. Chen, R. F. Gottesman, M. N. Bahouth, P. Gailloud, K. Murphy, R. Wityk, and N. R. Miller
Local Intraarterial Fibrinolysis Administered in Aliquots for the Treatment of Central Retinal Artery Occlusion: The Johns Hopkins Hospital Experience
Stroke, June 1, 2008; 39(6): 1746 - 1750.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
S. Polack, H. Kuper, W. Mathenge, A. Fletcher, and A. Foster
Cataract visual impairment and quality of life in a Kenyan population
Br. J. Ophthalmol., July 1, 2007; 91(7): 927 - 932.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
R. Nutheti, B. R. Shamanna, P. K. Nirmalan, J. E. Keeffe, S. Krishnaiah, G. N. Rao, and R. Thomas
Impact of Impaired Vision and Eye Disease on Quality of Life in Andhra Pradesh
Invest. Ophthalmol. Vis. Sci., November 1, 2006; 47(11): 4742 - 4748.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
J E Hale, S Murjaneh, N A Frost, and R A Harrad
How should we manage an amblyopic patient with cataract?
Br. J. Ophthalmol., February 1, 2006; 90(2): 132 - 133.
[Full Text] [PDF]


Home page
J. Epidemiol. Community HealthHome page
M. Muir
Hygieia
J Epidemiol Community Health, June 1, 2005; 59(6): 532 - 532.
[Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
H T V Vu, J E Keeffe, C A McCarty, and H R Taylor
Impact of unilateral and bilateral vision loss on quality of life
Br. J. Ophthalmol., March 1, 2005; 89(3): 360 - 363.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
O M Durrani, N N Tehrani, J E Marr, P Moradi, P Stavrou, and P I Murray
Degree, duration, and causes of visual loss in uveitis
Br. J. Ophthalmol., September 1, 2004; 88(9): 1159 - 1162.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
E.-M. Chia, J. J. Wang, E. Rochtchina, W. Smith, R. R. Cumming, and P. Mitchell
Impact of Bilateral Visual Impairment on Health-Related Quality of Life: the Blue Mountains Eye Study
Invest. Ophthalmol. Vis. Sci., January 1, 2004; 45(1): 71 - 76.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2003 by the BMJ Publishing Group Ltd.